Skip to main content
. 2021 Feb 9;14:369–380. doi: 10.2147/JPR.S293338

Table 3.

Point Prevalence of Musculoskeletal Pain by Anatomical Site, Sex and Age

Pain Site Sex Age Group P-value
18–29 30–39 40–49 50–59 ≥60
Shoulder Male 12.37 (9.03–16.71) 13.16 (9.37–18.16) 7.32 (3.90–13.32) 16.50 (10.57–24.85) 14.86 (8.51–24.69) 0.290
Female 17.14 (12.94–22.36) 17.83 (12.64–24.57) 20.49 (14.28–28.50) 16.67 (10.37–25.69) 11.11 (5.19–22.19) 0.669
Upper Arm Male 1.41 (0.55–3.58) 3.95 (2.09–7.33) 4.88 (2.25–10.23) 1.94 (0.53–6.81) 2.70 (0.74–9.33) 0.261
Female 3.27 (1.66–6.31) 3.18 (1.37–7.24) 0.00 (0.00–3.05) 0.00 (0.00–4.09) 1.85 (0.33–9.77) 0.131
Elbow Male 1.41 (0.55–3.58) 2.19 (0.94–5.03) 1.63 (0.45–5.74) 0.97 (0.17–5.30) 4.05 (1.39–11.25) 0.575
Female 0.41 (7e-04–2.28) 3.18 (1.37–7.24) 2.46 (0.84–6.98) 4.44 (1.74–10.88) 1.85 (0.33–9.77) 0.146
Forearm Male 1.77 (0.76–4.07) 2.19 (0.94–5.03) 1.63 (0.45–5.74) 4.85 (2.09–10.86) 4.05 (1.39–11.25) 0.376
Female 3.27 (1.66–6.31) 1.27 (0.35–4.53) 0.82 (0.14–4.50) 5.56 (2.40–12.35) 1.85 (0.33–9.77) 0.172
Wrist/Hand Male 3.53 (1.93–6.38) 1.75 (0.68–4.42) 1.63 (0.45–5.74) 5.83 (2.70–12.13) 8.11 (3.77–16.58) 0.045
Female 3.27 (1.66–6.31) 3.18 (1.37–7.24) 4.10 (1.76–9.24) 10.00 (5.35–17.92) 1.85 (0.33–9.77) 0.056
Head Male 12.72 (9.33–17.11) 10.09 (6.82–14.68) 12.20 (7.53–19.15) 15.53 (9.79–23.75) 16.22 (9.53–26.24) 0.555
Female 14.69 (10.81–19.67) 23.57 (17.61–30.79) 19.67 (13.59–27.60) 15.56 (9.50–24.43) 5.56 (1.91–15.11) 0.022
Neck Male 6.36 (4.06–9.83) 12.28 (8.63–17.18) 11.38 (6.90–18.20) 17.48 (11.35–25.94) 17.57 (10.56–27.77) 0.007
Female 17.14 (12.94–22.36) 13.38 (8.92–19.58) 13.11 (8.24–20.25) 10.00 (5.35–17.92) 5.56 (1.91–15.11) 0.158
Thoracic Male 13.07 (9.64–17.50) 10.96 (7.54–15.69) 8.13 (4.48–14.32) 12.62 (7.53–20.40) 13.51 (7.51–23.12) 0.650
Female 13.88 (10.10–18.77) 12.74 (8.40–18.86) 6.56 (3.36–12.41) 17.78 (11.25–26.94) 11.11 (5.19–22.19) 0.151
Lumbar Male 19.43 (15.25–24.44) 28.07 (22.64–34.23) 28.46 (21.23–36.99) 32.04 (23.81–41.56) 36.49 (26.44–47.87) 0.010
Female 31.43 (25.94–37.49) 32.48 (25.65–40.15) 32.79 (25.09–41.53) 21.11 (13.95–30.63) 37.04 (25.42–50.37) 0.249
Hip/Pelvis Male 1.41 (0.55–3.58) 2.19 (0.94–5.03) 1.63 (0.45–5.74) 2.91 (1.00–8.22) 13.51 (7.51–23.12) 0.000
Female 6.12 (3.75–9.85) 2.55 (1.00–6.37) 6.56 (3.36–12.41) 14.44 (8.64–23.16) 9.26 (4.02–19.91) 0.009
Thigh Male 11.66 (8.42–15.92) 13.16 (9.37–18.16) 8.94 (5.07–15.31) 10.68 (6.07–18.12) 17.57 (10.56–27.77) 0.445
Female 19.59 (15.11–25.01) 13.38 (8.92–19.58) 12.30 (7.59–19.30) 11.11 (6.15–19.26) 3.70 (1.02–12.54) 0.019
Knee Male 12.37 (9.03–16.71) 17.98 (13.54–23.48) 19.51 (13.48–27.39) 30.10 (22.09–39.54) 39.19 (28.86–50.58) 0.000
Female 17.96 (13.66–23.25) 14.01 (9.44–20.31) 28.69 (21.41–37.27) 46.67 (36.71–56.90) 37.04 (25.42–50.37) 0.000
Leg Male 24.03 (19.42–29.33) 25.44 (20.22–31.47) 26.02 (19.07–34.41) 24.27 (17.02–33.38) 43.24 (32.57–54.59) 0.018
Female 36.33 (30.56–42.52) 28.03 (21.59–35.51) 30.33 (22.87–38.98) 38.89 (29.47–49.22) 40.74 (28.68–54.03) 0.209
Ankle/Foot Male 43.46 (37.81–49.29) 37.72 (31.68–44.17) 35.77 (27.85–44.56) 24.27 (17.02–33.38) 35.14 (25.24–46.50) 0.015
Female 42.86 (36.82–49.12) 40.76 (33.39–48.58) 34.43 (26.59–43.22) 41.11 (31.51–51.44) 27.78 (17.62–40.89) 0.216
Lower Extremitya Male 57.60 (51.78–63.22) 60.09 (53.61–66.23) 60.98 (52.15–69.14) 59.22 (49.57–68.22) 77.03 (66.25–85.13) 0.049
Female 71.84 (65.90–77.10) 66.24 (58.54–73.17) 68.85 (60.17–76.39) 78.89 (69.37–86.05) 72.22 (59.11–82.38) 0.304
Allb Male 69.96 (64.39–75.01) 77.19 (71.32–82.16) 80.49 (72.61–86.52) 78.64 (69.77–85.45) 83.78 (73.76–90.47) 0.040
Female 85.71 (80.78–89.55) 82.80 (76.13–87.90) 86.89 (79.75–91.76) 90.00 (82.08–94.65) 87.04 (75.58–93.58) 0.616

Notes: aMusculoskeletal pain at the hip/pelvis, thigh, knee, leg and ankle/foot sites. bMusculoskeletal pain at any site. The results of point prevalence of musculoskeletal pain with 95% CIs are presented as percentages (%). Based on Pearson’s chi-squared tests, the values of statistically significant differences (P<0.05) between sexes (prevalence values) and age groups (P-values) are shown in bold.